Ovarian Epithelial Carcinoma
📧 Sign up to get email alerts when something new happens for Ovarian Epithelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab and bevacizumab with chemotherapy followed by pembrolizumab, bevacizumab, and olaparib in recurrent o…
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating the pharmacokinetics and safety of OvaRex MAb-B43.13 in ovarian epithelial carcinoma has been terminated.